Skip to main content

Ketamine Injection

Last Updated: December 23, 2022
Status: Current

Products Affected - Description
    • Ketalar injection, Par Pharmaceuticals, 10 mg/mL, 20 mL vial, 10 count, NDC 42023-0113-10
    • Ketalar injection, Par Pharmaceuticals, 100 mg/mL, 5 mL vial, 10 count, NDC 42023-0115-10
    • Ketalar injection, Par Pharmaceuticals, 50 mg/mL, 10 mL vial, 10 count, NDC 42023-0114-10
    • Ketamine injection, Eugia US, 50 mg/mL, 10 mL vial, 10 count, NDC 55150-0439-10
    • Ketamine injection, Hikma, 100 mg/mL, 5 mL vial, 10 count, NDC 00143-9509-10
    • Ketamine injection, Hikma, 50 mg/mL, 10 mL vial, 10 count, NDC 00143-9508-10
    • Ketamine injection, Pfizer, 100 mg/mL, 5 mL vial, 10 count, NDC 00409-2051-05
    • Ketamine injection, Pfizer, 50 mg/mL, 10 mL vial, 10 count, NDC 00409-2053-10
Reason for the Shortage
    • AuroMedics (Eugia) has ketamine on shortage due to increased demand.
    • Hikma has ketamine injection on shortage due to increased demand.
    • Mylan Institutional divested ketamine to AuroMedics.
    • Par has Ketalar on shortage due to increased demand.
    • Pfizer has ketamine on shortage due to manufacturing delays.
Available Products
    • Ketamine injection, Eugia US, 10 mg/mL, 20 mL vial, 10 count, NDC 55150-0438-10
    • Ketamine injection, Eugia US, 100 mg/mL, 10 mL vial, 10 count, NDC 55150-0440-10

Estimated Resupply Dates

    • Eugia has ketamine 50 mg/mL 10 mL vials are on intermittent back order and the company is releasing product as it becomes available.
    • Hikma has ketamine 100 mg/mL 5 mL vials and 50 mg/mL 10 mL vials on a long-term back order and the company cannot estimate a release date.
    • Pfizer has ketamine 50 mg/mL 10 mL vials on back order and the company estimates a release date of February 2025. The 100 mg/mL 5 mL vials are available in limited supply.
    • Par has regular releases of Ketalar vials but supply is depleted as it becomes available.

Alternative Agents & Management

    • There are practice guidelines available for moderate procedural sedation and analgesia. These are available at https://pubs.asahq.org/anesthesiology/article/128/3/437/18818/Practice-Guidelines-for-Moderate-Procedural.

Updated

Updated December 23, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 7, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.